Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel? - Clinical Genitourinary Cancer
Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer - European Journal of Cancer
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry.,Prostate Cancer and Prostatic Diseases - X-MOL
The Clinical Efficacy of Enzalutamide in Metastatic Prostate Cancer: Prospective Single-center Study | Anticancer Research
A) Prostate cancer–specific survival and (B) overall survival... | Download Scientific Diagram
Patients with Localised Prostate Cancer (T1 - T2) Show Improved Overall Long-Term Survival Compared to the Normal Population
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer - Annals of Oncology
Kaplan-Meier analysis of overall survival among prostate cancer... | Download Scientific Diagram
Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era - International Journal of Radiation Oncology, Biology, Physics
Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer - Clinical Genitourinary Cancer
Oncotarget: Melatonin increases overall survival of prostate cancer patients | Oncotarget
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data - The Lancet Oncology
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model - European Urology
TITAN trials demonstrates significantly Improved Overall Survival and Radiographic Progression-Free Survival for Apalutamide in Patients with Metastatic Castration-Sensitive Prostate Cancer - Onco Americas
SciELO - Brasil - Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center Prostate cancer incidentally discovered at the
Overall survival of metastatic prostate cancer patients starting... | Download Scientific Diagram
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study - The Lancet Oncology
Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England | Prostate Cancer and Prostatic Diseases
Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH - ScienceDirect
PLOS ONE: Overall survival and second primary malignancies in men with metastatic prostate cancer
ASCO GU 2022: The Changing Landscape of Treatment and Survival for Men with Castration-Resistant Prostate Cancer in the Era of Novel Treatments
Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018) | BMC Cancer | Full Text
PLOS ONE: Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer - European Urology
prostate cancer and hormones
